Guidance for industry : supplemental guidance on testing for replication competent retrovirus in reroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors.
| Corporate Author: | Center for Biologics Evaluation and Research (U.S.) |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,
[2006]
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/LPS112495 |
Similar Items
Guidance for industry : gene therapy clinical trials, observing subjects for delayed adverse events.
Published: (2006)
Published: (2006)
Viral Vectors for Treating Diseases of the Nervous System /
Published: (2003)
Published: (2003)
Retroviruses and disease /
Published: (1989)
Published: (1989)
Retroviruses and primate genome evolution /
Published: (2005)
Published: (2005)
Gene therapy methods /
Published: (2002)
Published: (2002)
Retroviruses : molecular biology, genomics and pathogenesis /
Published: (2010)
Published: (2010)
Self-assembling complexes for gene delivery : from laboratory to clinical trial /
Published: (1998)
Published: (1998)
Structures and functions of retroviral RNAs : the multiple facets of the retroviral genome /
by: Fosse, Philippe
Published: (2022)
by: Fosse, Philippe
Published: (2022)
Transacting functions of human retroviruses /
Published: (1995)
Published: (1995)
Retroviruses and primate genome evolution /
Published: (2005)
Published: (2005)
Retrovirus-Cell Interactions /
Published: (2018)
Published: (2018)
Human retroviral infections : immunological and therapeutic control /
Published: (2002)
Published: (2002)
Guidance for industry : guidance for human somatic cell therapy and gene therapy.
Published: (1998)
Published: (1998)
Gene therapy of cancer /
Published: (1998)
Published: (1998)
21st congress of the IABS on progress in animal retroviruses : proceedings of a symposium organized by the International Association of Biological Standardization held at the Centre Bonlieu, Annecy, France 4-6 October 1989 ; co-sponsored by the World Health Organization.
Published: (1990)
Published: (1990)
Guidance for industry : potency tests for cellular and gene therapy products.
Published: (2008)
Published: (2008)
Lentiviral vectors /
Published: (2002)
Published: (2002)
Gene therapy : is there oversight for patient safety? : hearing before the Subcommittee on Public Health of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... February 2, 2000.
Published: (2000)
Published: (2000)
Gene therapy : are patients any safer? : hearing before the Subcommittee on Public Health of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... May 25, 2000.
Published: (2000)
Published: (2000)
Guidance for clinical trial sponsors : establishment and operation of clinical trial data monitoring committees.
Published: (2006)
Published: (2006)
The Human retroviruses /
Published: (1991)
Published: (1991)
Clinical trials of genetic therapy with antisense DNA and DNA vectors /
Published: (1998)
Published: (1998)
Guidance for industry : E 10 choice of control group and related issues in clinical trials.
Published: (2001)
Published: (2001)
Guidance for industry : information program on clinical trials for serious or life-threatening diseases and conditions.
Published: (2002)
Published: (2002)
Guidance for industry : computerized systems used in clinical trials.
Published: (1999)
Published: (1999)
Guidance for industry : acceptance of foreign clinical studies.
Published: (2001)
Published: (2001)
Improving the quality of cancer clinical trials : workshop summary /
Published: (2008)
Published: (2008)
Human retroviral infections : immunological and therapeutic control /
Published: (2000)
Published: (2000)
Guidance for industry : E9 statistical principles for clinical trials.
Published: (1998)
Published: (1998)
Guidance for industry : collection of race and ethnicity data in clinical trials.
Published: (2005)
Published: (2005)
Guidance for FDA reviews and sponsors : content and review of chemistry, manufacturing, and control (CMC) information for human gene therapy investigational new drug applications (INDs).
Published: (2008)
Published: (2008)
Guidance for industry : toxicity grading schedule for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials.
Published: (2007)
Published: (2007)
The Search For A Distal Promoter Element In The Mouse Mammary Tumor Virus.
by: Zera, Evelyn M.
Published: (1993)
by: Zera, Evelyn M.
Published: (1993)
Guidance for industry : computerized systems used in clinical investigations.
Published: (2007)
Published: (2007)
Adenoviral vectors for gene therapy /
Published: (2025)
Published: (2025)
Guidance for industry : E6 good clinical practice, consolidated guidance.
Published: (1996)
Published: (1996)